On Stockhead today, what the newly implemented Basel III regulations mean for gold, a Chinese lithium giant betting on lithium rising further and how to profit from the winds of change in global interest rates.


But first … the day ahead.

Scheduled to list at 11am EST is Polymetals Resources (ASX:POL), an explorer hunting gold deposits in the West African nation of Guinea.



The following companies are in trading halts and are expected to exit over the next two trading days:


Proteomics (ASX:PIQ) – conference presentation
Creso Pharma (ASX:CPH) – sales and revenue update
Mineral Commodities (ASX:MRC) – capital raising
Matador Mining (ASX:MZZ) – capital raising
DigitalX (ASX:DCC) – revenue recognition update
Hydrix (ASX:HYD) – AngelMed distribution update
PropTech Group (ASX:PTG) – capital raising


EP&T Global (ASX:EPX) – contract award
TNT Mines (ASX:TIN) – capital raising
Zinc of Ireland (ASX:ZMI) – acquisition and capital raising
TerraCom (ASX:TER) – bond maturity
IODM (ASX:IOD) – revenue signing
Elixinol (ASX:EXL) – acquisition update
Mako Gold (ASX:MKG) – acquisition



Gold: $US1,777.98 ($2,349.69) (-0.13%)

Silver: $US26.10 ($34.49) (+0.10%)

Oil (WTI): $US72.77 (-1.73%)

Oil (Brent): $US74.59 (-2.09%)

Coal: $US124.10 (-2.40%)

Iron 62pc Fe: $US215.26 (+0.51%)

AUD/USD: $US0.7567 (-0.25%)

Bitcoin: $US34,598.63 (+6.39%)



Everyone deals with a lockdown in their own way.

To keep up to date with Stockhead coverage, follow our Twitter page or sign up to our members-only Facebook group here.

For all you crypto lovers Stockhead’s Cryptohead Facebook group is the place to share your views, insights, tips and ideas.

Also, be sure to check in at 10.20am each day for our daily ‘10 at 10’ column — a live summary of winners & losers at the opening bell.



Scroll or swipe to reveal table. Click headings to sort.

Atomo Diagnostics (ASX:AT1) had a jointly developed COVID-19 test given Emergency Use Authorisation by the FDA.

Hydrix (ASX:HYD) also got FDA approval for its medical device, namely the heart monitoring device AngelMed Guardian.

In resources, Indonesia focused gold play Nusantara Resources (ASX:NUS) got a takeover offer.

Cloud-based software as a service (SaaS) logistics company Yojee (ASX:YOJ) also rose after landing an expanded deal with an unnamed multinational customer, which will would result Yojee getting access to 18 additional markets in the Asia-Pacific where the customer operates.



Scroll or swipe to reveal table. Click headings to sort.

Cyclopharm (ASX:CYC)  was sent back to the drawing board by the FDA.

The FDA advised that it could not approve Cyclopharm’s nuclear lung imaging agent Technegas in its present form and provided a list of items and recommendations for outstanding elements to be addressed within the next 12 months.

The ASX’s newest gold explorer Barton Gold (ASX:BGD) fell on its ASX debut.